2022
Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol
Ondersma SJ, Todd L, Jablonski S, Ahuja C, Gilstad-Hayden K, Goyert G, Loree A, Heffner J, Yonkers KA. Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol. BMJ Open 2022, 12: e062735. PMID: 35922101, PMCID: PMC9352990, DOI: 10.1136/bmjopen-2022-062735.Peer-Reviewed Original ResearchConceptsPregnant womenBrief interventionAlcohol useFactorial trialHealth Institutional Review BoardAdverse perinatal outcomesFetal alcohol spectrum disordersUnhealthy alcohol useDose-response effectPrenatal alcohol exposureSpectrum of conditionsAlcohol spectrum disordersInstitutional review boardText messagingPeer-reviewed journalsPerinatal outcomesWeeks' gestationBirth outcomesPossible additional benefitsStudy protocolAlcohol exposureAlcohol abstinenceBooster sessionsEthical approvalPrimary analysis
2017
Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry 2017, 74: 1145-1152. PMID: 28903165, PMCID: PMC5710298, DOI: 10.1001/jamapsychiatry.2017.2733.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitor useAdverse birth outcomesLow birth weightSerotonin reuptake inhibitorsWeeks of pregnancyHypertensive diseaseDuration of gestationRespiratory interventionsVentilatory supportCesarean deliveryReuptake inhibitorsPanic disorderPregnancy outcomesInhibitor usePreterm birthBirth outcomesBenzodiazepine treatmentBirth weightAnxiety disordersWorld Mental Health Composite International Diagnostic InterviewPrevious adverse birth outcomesComposite International Diagnostic InterviewAdverse pregnancy complicationsMaternal panic disorderNeonatal pregnancy outcomes
2015
Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy. Obstetrics And Gynecology 2015, 125: 1224-1235. PMID: 25932852, PMCID: PMC4418034, DOI: 10.1097/aog.0000000000000759.Peer-Reviewed Original ResearchConceptsAdverse birth outcomesGestational-age birthsAntipsychotic exposureNeonatal outcomesCohort studyBirth outcomesAntipsychotic medicationMajor malformationsBirth weightOdds ratioAntipsychotic medication exposureNeonatal birth weightPooled odds ratioPotential risk factorsUnexposed pregnanciesMedication exposurePreterm deliveryGestational ageAntipsychotic treatmentElective terminationPossible confoundersReproductive ageRisk factorsSpontaneous abortionSTUDY SELECTION
2012
Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth
Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K. Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth. Epidemiology 2012, 23: 677-685. PMID: 22627901, PMCID: PMC3415566, DOI: 10.1097/ede.0b013e31825838e9.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitorsMajor depressive episodePreterm birthDepressive episodeLogistic regressionSRI useUse of SRIsSerotonin reuptake inhibitor treatmentReuptake inhibitor treatmentEarly preterm birthLate preterm birthProspective cohort studyPreterm birth riskMajor depressive disorderNominal logistic regressionBinary logistic regressionAntidepressant treatmentCohort studyHospital chartsReuptake inhibitorsSymptomatic womenBirth outcomesPregnant womenRisk factorsDepressive disorder